Physician

Adnan Anwer Qureshi, M.D.

According to 2025 Medicare claims, Adnan Qureshi, M.D. (NPI: 1154641702) practices pain management in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bronx, NY. This provider's primary affiliated billing organization is CASTLE HILL MEDICAL OF NEW YORK, INC. (NPI: 1205949997; TIN: 200358994) and primary practice location at 10473-1320. Qureshi is affiliated with the SOMOS ACO (ACO ID: A4577), participating under the MSSP model.

Qureshi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 88 traditional Medicare patients, billed 6,655 HCPCS/CPT codes, and received $141,758 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 504 prescription claims across 117 beneficiaries totaling $97,435 in drug costs, led by Ztlido (Lidocaine). 2015 DME data shows 70 claims. Open Payments data shows 2 records totaling $4,864. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $167,476 and ending at $141,758. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $96,268 and ending at $97,435. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	353	3,400	$167,476
2016	390	3,468	$193,724
2017	126	473	$25,891
2018	140	7,050	$154,209
2019	155	9,203	$204,159
2020	107	4,783	$111,217
2021	105	6,669	$158,658
2022	99	5,381	$128,031
2023	98	7,379	$166,513
2024	88	6,655	$141,758

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	228	945	$96,268
2016	255	1,069	$111,276
2017	119	372	$39,483
2018	168	686	$230,535
2019	198	768	$297,715
2020	104	427	$186,089
2021	137	477	$115,592
2022	166	608	$171,471
2023	118	472	$112,504
2024	117	504	$97,435

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	70	$1,920
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	19	19	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	60	125	$77
97124	Therapy procedure using massage, each 15 minutes	61	934	$26
97110	Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes	79	3,230	$19
97032	Application of electrical stimulation with therapist present, each 15 minutes	41	625	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ztlido	Lidocaine	73	3,180	$45,002
Vascepa	Icosapent Ethyl	55	1,995	$22,399
Diclofenac Sodium	Diclofenac Sodium	56	3,031	$9,007
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	81	2,360	$3,728
Piroxicam	Piroxicam	18	540	$3,144

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$4,864	Chiesi USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adnan Anwer Qureshi, M.D.?

Tedicare shows public-source Medicare data for Adnan Anwer Qureshi, M.D. (NPI 1154641702), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adnan Anwer Qureshi, M.D. have ACO affiliation data?

Adnan Anwer Qureshi, M.D. is shown with ACO affiliation data for SOMOS ACO (MSSP, ACO ID A4577).

What billing organization is linked to Adnan Anwer Qureshi, M.D.?

Adnan Anwer Qureshi, M.D. is linked to CASTLE HILL MEDICAL OF NEW YORK, INC. (billing NPI 1205949997) in the available physician profile data.

Does Adnan Anwer Qureshi, M.D. have Open Payments data?

Adnan Anwer Qureshi, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.